Controlled nanoparticle synthesis of Ag/Fe co-doped hydroxyapatite system for cancer cell treatment.

Controlled nanoparticle synthesis of Ag/Fe co-doped hydroxyapatite system for cancer cell treatment.

Veerla, Sarath Chandra;Kim, Da Reum;Kim, Jongjun;Sohn, Honglae;Yang, Sung Yun;
materials science & engineering c, materials for biological applications 2019 Vol. 98 pp. 311-323
426
veerla2019controlled

Abstract

Diagnosis of cancer by chemotherapy treatment, severe side effects caused by high dosages of cancer drugs include non-controlled cytotoxicity to bone marrow cells and immune cells. To overcome, we have synthesized nanoparticles with controlled sized hydroxyapatite (nHAp) materials doped and co-doped with silver and iron by co-precipitation, yielding materials that can treat both the infections and malignant tumors with non-cytotoxic nature to normal cells. Spherical and rod like morphologies were observed for the samples with higher Ag doping concentrations with average size of 50 ± 5 nm and (75 × 22) ± 5 nm, whereas higher Ag/Fe co-doping concentrations yielded samples with spherical, rod-like, and flake-like structures. For samples nHAp and Ag-nHAp samples were diamagnetic, whereas the Fe-nHAp and Ag/Fe co-doped samples were superparamagnetic. The in vitro biological toxicity study revealed that the Ag/Fe-nHAp nanoparticles are effective for targeting to kill cancerous cells, for example, human cervical cancer (HeLa) cells efficiently while they are non-toxic to normal cells. Applying these nanoparticles for drug delivery system, 5-fluorouracil was loaded in the nanoparticles and studied its release kinetics. In the case of Ag/Feco-doped nHAp samples, a pulsatile drug release profile was observed, which the drug was released for about a week on varying the Ag and Fe concentrations. The 5-fluorouracil release kinetics was well fitted by the first-order model with diffusion. Thus, nHAps co-doped with Ag/Fe material have the potential to lag the time on delivering the drug at site-specific could be with an application in biomedicine such as to treat malignant tumor without any bacterial side effect.

Citation

ID: 933
Ref Key: veerla2019controlled
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
933
Unique Identifier:
S0928-4931(17)34471-5
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet